Liabilities and Equity in USD of Liminatus Pharma, Inc. from Q4 2024 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Summary
Liminatus Pharma, Inc. quarterly Liabilities and Equity history and change rate from Q4 2024 to Q3 2025.
  • Liminatus Pharma, Inc. Liabilities and Equity for the quarter ending 30 Sep 2025 was $1.34M.
Liabilities and Equity, Quarterly (USD)

Liminatus Pharma, Inc. Quarterly Liabilities and Equity (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $1.34M 30 Sep 2025 10-Q 14 Nov 2025
Q2 2025 $1.91M 30 Jun 2025 10-Q 06 Oct 2025
Q4 2024 $5.41M 31 Dec 2024 10-Q 14 Nov 2025
* An asterisk sign (*) next to the value indicates that the value is likely invalid.